Plasma and Peritoneal Fluid Fibronectin and Collagen IV Levels as Potential Biomarkers of Endometriosis

Laparoscopy as a diagnostic tool for patients with suspected endometriosis is associated with several potentially life-threatening complications. Therefore, it is imperative to identify reliable, non-invasive biomarkers of the disease. The aim of this study was to analyse the concentrations of fibronectin and type IV collagen in peritoneal fluid and plasma to assess their role as potential biomarkers in the diagnosis of endometriosis. Fibronectin and collagen IV protein levels were assessed by surface plasmon resonance imaging (SPRi) biosensors with the usage of monoclonal antibodies. All patients enrolled in the study were referred for laparoscopy for the diagnosis of infertility or chronic pelvic pain (n = 84). The study group included patients with endometriosis confirmed during surgery (n = 49). The concentration of fibronectin in the plasma (329.3 +/- 98.5 mg/L) and peritoneal fluid (26.8 +/- 11.1 mu g/L) in women with endometriosis was significantly higher than in the control group (251.2 +/- 84.0 mg/L, 7.0 +/- 5.9 mu g/L). Fibronectin levels were independent of endometriosis stage (p = 0.874, p = 0.469). No significant differences were observed in collagen IV levels (p = 0.385, p = 0.465). The presence of elevated levels of fibronectin may indicate abnormalities in cell-ECM signalling during the course of endometriosis, and may be a potential biomarker for early detection.

Automated summary

This study analyzed the concentrations of fibronectin and type IV collagen in peritoneal fluid and plasma, aiming to evaluate their potential as biomarkers for the diagnosis of endometriosis. The findings suggest that elevated levels of fibronectin may indicate abnormalities in cell-ECM signaling during the course of endometriosis, and could be a potential biomarker for early detection.